Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2003
09/09/2003US6617299 Composition and method for bleaching a substrate
09/09/2003US6617282 Useful as herbicides, defoliants and desiccants.
09/09/2003CA2290712C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
09/09/2003CA2078814C Substituted pyridinylamino-1h-indoles, 1h-indazoles, 2h-indazoles, benzo[b]thiophenes and 1,2-benzisothiazoles, a process for their preparation and their use as medicaments
09/04/2003WO2003072574A1 Piperidine ouracil used as a medicament for treating bacterial infections
09/04/2003WO2003072572A1 Beta3-adrenergic receptor agonists
09/04/2003WO2003072569A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
09/04/2003WO2003072551A1 Uracil-thioether
09/04/2003WO2003072550A1 Novel fused ring indazole compounds
09/04/2003WO2003072549A1 Farnesyl protein transferase inhibitors as antitumor agents
09/04/2003WO2003072548A1 Pyridyl sulfone derivatives as 5-ht receptor antagonists
09/04/2003WO2003072197A1 Acc inhibitors
09/04/2003WO2003072159A1 N-{5-[4-(4-methyl-piperazino-methyl)­-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
09/04/2003WO2003072107A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003WO2003072106A2 Use of tyrosine kinase inhibitors for treating substance use disorders
09/04/2003WO2003072056A2 Intranasal administration of mc4-r agonists
09/04/2003WO2003063840A3 Transmucosal delivery of proton pump inhibitors
09/04/2003WO2003062209A3 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
09/04/2003WO2003045313A3 2-aminoquinoline compounds
09/04/2003WO2003037891A8 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
09/04/2003WO2003035646A3 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
09/04/2003WO2003029244A8 Process for preparing pyridyl-alkylsulfonyl pyrazole derivatives
09/04/2003WO2002093164A3 Pyridylpyrimidine derivatives as effective compounds against prion diseases
09/04/2003WO2002068387A8 Acylated piperidine derivatives as melanocortin-4 receptor agonists
09/04/2003US20030166963 Using tertiary amine catalyst
09/04/2003US20030166939 Free radical catalysts for unsaturated polymers
09/04/2003US20030166937 Fine particle size; anticoagulant
09/04/2003US20030166931 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
09/04/2003US20030166930 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
09/04/2003US20030166702 Contacting carvedilol and ethyl acetate to form a solution, and cooling the solution whereby a precipitate is formed; hypotensive agent
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166687 Alpha-hydroxy,-amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors
09/04/2003US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer
09/04/2003US20030166675 Substituted quinolin-2-one derivatives useful as antiproliferative agents
09/04/2003US20030166672 Derivatives of 4-(Thio- or Selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
09/04/2003US20030166665 4-,5-,6-And 7-indole derivatives useful for the treatment of CNS disorders
09/04/2003US20030166664 E.g. 3-(1-(2-(5-(acetylamino)-2-methylphenyl)ethyl)piperidin--4-yl)-6-chloro-1H -indole; potent dopamine D4 ligands, dopamine antagonists; antiseratonin agents; psychoses; anxiolytic agents; antidepressants; side effects reduction
09/04/2003US20030166658 Condensing a heterocyclic ketone or aldehyde with a 2-(NH2-NH-)benzimidazole, -oxazole or -thiazole; ribonucleotide reductase inhibitors; anticarcinogenic and -tumor agents; also useful against multidrug resistant cells
09/04/2003US20030166652 Chemical compounds
09/04/2003US20030166649 E.g., 4-(2-(1-Benzhydryl-2-(2-((benzylsulfonyl)amino)ethyl)-5-chloro-1H-indol-3 -yl)ethoxy)benzoic acid; inhibitors of phospholipase enzymes, esp. phospholipase A2; antiarthritic and -inflammatory agents; analgesics; rheumatoid diseases
09/04/2003US20030166647 Nitrogen compounds such as 5-(4-(Benzyloxy)benzyl)-5-methyl-2, 4,6(1H,3H,5H)-pyrimidinetrione, used as enzyme inhibitors, used as antiinflammatory agents
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166639 Dihydro-benzo[b][1,4]diazepin-2-one derivatives
09/04/2003US20030166638 Technical field
09/04/2003US20030166637 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9H-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
09/04/2003US20030166636 Hydroxyalkanoylaminolactams and related structures as inhibitors of A-beta protein production
09/04/2003US20030166635 Novel 2-nitromethylidene/2-cyanimino/2-nitro-imino-pyrrolidines and piperidines, intermediates, and their use as pesticides
09/04/2003US20030166633 Pyridinylimidazoles
09/04/2003US20030166616 A tachykinin antagonist for used as antiinflammatory agent, antiallergic agent, analgesic, antiemetics, treating irritable colon syndrome, skin disorders
09/04/2003US20030166590 Microsomal triglyceride transfer protein
09/04/2003US20030166579 Thrombin inhibitors comprising an aminoisoquinoline group
09/04/2003US20030166578 Combinations od dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
09/04/2003US20030163876 For dyeing hair; efficiency
09/04/2003CA2477726A1 Use of tyrosine kinase inhibitors for treating substance use disorders
09/04/2003CA2477558A1 N-{5-[4-(4-methyl-piperazino-methyl)­-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
09/04/2003CA2477328A1 Pyridyl tricyclic compounds as farnesyl protein transferase inhibitors and antitumor agents
09/04/2003CA2477287A1 Uracil-thioether
09/04/2003CA2477224A1 Piperidine ouracil used as a medicament for treating bacterial infections
09/04/2003CA2477008A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003CA2476316A1 Beta3-adrenergic receptor agonists
09/03/2003EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/03/2003EP1340753A1 Carbamate derivatives, process for producing the same and use thereof
09/03/2003EP1340748A1 Quinazoline derivatives and drugs
09/03/2003EP1340744A2 Hiv protease inhibitors
09/03/2003EP1340498A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
09/03/2003EP1339708A2 Indole-type inhibitors of p38 kinase
09/03/2003EP1339706A1 N-type calcium channel antagonists for the treatment of pain
09/03/2003EP1339699A1 Substituted amidoalkyl uracils and the use thereof
09/03/2003EP1339698A2 Pyrimidine derivatives
09/03/2003EP1339695A1 Farnesyltransferase inhibitors
09/03/2003EP1339692A1 Novel compounds for use as hiv protease inhibitors
09/03/2003EP1339691A1 Novel compounds
09/03/2003EP1339688A1 N-type calcium channel antagonists for the treatment of pain
09/03/2003EP1339687A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents
09/03/2003EP1339684A1 Mch antagonists and their use in the treatment of obesity
09/03/2003EP1339683A2 Estrogen receptor modulators
09/03/2003EP1339681A1 Synthesis of fused pyrrolecarboxamides
09/03/2003EP1339680A1 Substituted oxindole derivatives as tyrosine kinase inhibitors
09/03/2003EP1339677A1 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis
09/03/2003EP1339407A1 Farnesyl protein transferase inhibitors for the treatment of inflammatory bowel disease
09/03/2003EP1113822B1 Near infrared fluorescent contrast agent and fluorescence imaging
09/03/2003EP1095038B1 Antagonists of gonadotropin releasing hormone
09/03/2003EP1077947B1 Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments
09/03/2003EP1060178B1 Heterocyclic compounds as inhibitors of rotamase enzymes
09/03/2003EP0993454B1 Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
09/03/2003EP0977741B1 Substituted phenyl derivatives, their preparation and use
09/03/2003EP0945445B1 1,5-benzodiazepine derivatives
09/03/2003EP0612318B1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
09/03/2003CN1440405A Sulfonyl-pyrrolidine derivatives useful for treatment of neurological disorders
09/03/2003CN1440404A Benzofuran derivatives and their use as antibacterial agents
09/03/2003CN1440402A N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
09/03/2003CN1440393A Cyclic compounds
09/03/2003CN1440392A Phenylpyridazine derivatives and drugs containing the same
09/03/2003CN1440391A Propane-1,3-dione derivatives
09/03/2003CN1440385A Pyrrole derivatives for treating AIDS
09/03/2003CN1120167C Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles having an affinity for alpha and/or 5HTIA receptors
09/03/2003CN1120165C Block oligomers containing 2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
09/03/2003CN1120159C Intermediate for preparing 1,4-disubstituted tetraazole-quinolinone
09/03/2003CN1120155C 2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals
09/03/2003CN1120154C 4-hydroxy-piperdine derivatives